Inicio › Afecciones posteriores al COVID-19 (COVID-19 persistente) › Nueva York › New York City
Ensayos clínicos de Afecciones posteriores al COVID-19 (COVID-19 persistente) en New York City, NY
15 estudios para Afecciones posteriores al COVID-19 (COVID-19 persistente) buscan participantes en centros de New York City y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
ReclutandoEstudio observacional
- Columbia University Medical Center, New York
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
ReclutandoFase 3
- Weill Cornell Medical College ( Site 3814), New York
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
ReclutandoFase 3
- Research Site, New York
Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers
ReclutandoFase 1 temprana
- Weill Cornell Medicine, New York
Long-Covid-19 Alleviation Through Learning Mindfulness Study
ReclutandoSe aceptan voluntarios sanos
- Columbia University, New York
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
ReclutandoFase 3
- Weill Cornell Medical College, New York
Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19
ReclutandoFase 3
- Icahn School of Medicine at Mount Sinai, New York
ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- NewYork-Presbyterian Hosptial/Columbia University Irving Medical Center, New York
Antiviral Clinical Trial for Long Covid-19
ReclutandoFase 2
- The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE), New York
Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
ReclutandoFase 1/2
- The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE), New York
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- New York Presbyterian Queens, New York
- Weill Cornell Medicine/New-York Presbyterian Hospital, New York
Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19)
Reclutando
- New York University Grossman School of Medicine, New York
COVID-19 Survivorship Registry
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- NYU Langone Health, New York
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
ReclutandoFase 3
- Columbia University Irving Medical Center, New York
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
ReclutandoFase 3
- Memorial Sloan Kettering Cancer Center, New York
Más información sobre Afecciones posteriores al COVID-19 (COVID-19 persistente) en MedlinePlus
Ensayos de Afecciones posteriores al COVID-19 (COVID-19 persistente) en otras ciudades
- Houston, TX13 estudios
- Boston, MA13 estudios
- Baltimore, MD12 estudios
- Chicago, IL11 estudios
- Washington, DC10 estudios
- San Francisco, CA8 estudios
- Durham, NC8 estudios
- Atlanta, GA8 estudios
- San Diego, CA7 estudios
- Los Angeles, CA6 estudios
- Pittsburgh, PA6 estudios
- Hialeah, FL6 estudios
Otros estudios en New York City
- Cáncer de seno136 estudios
- Cáncer de pulmón de células no pequeñas121 estudios
- Cáncer (todos los tipos)109 estudios
- Cáncer de próstata103 estudios
- Cáncer metastásico93 estudios
- Cáncer del colon y del recto78 estudios
- Cáncer de ovario69 estudios
- Cáncer de pulmón60 estudios
- Mieloma múltiple60 estudios
- Cáncer de páncreas60 estudios
- Cáncer de endometrio52 estudios
- Leucemia mielógena aguda51 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.